Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antirheumatic agents: CNS toxicity and its avoidance.

W F Iobst1, C R Bridges, M G Regan-Smith

  • 1Rheumatology Department, Dartmouth Medical School, Hanover, New Hampshire.

Geriatrics
|April 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of parental acclimation and energy limitation in response to high CO<sub>2</sub> exposure in Atlantic cod.

Scientific reports·2018
Same author

Characterization of Ras k 1 a novel major allergen in Indian mackerel and identification of parvalbumin as the major fish allergen in 33 Asia-Pacific fish species.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017
Same author

Delivery of drugs, growth factors, genes and stem cells via intrapericardial, epicardial and intramyocardial routes for sustained local targeted therapy of myocardial disease.

Expert opinion on drug delivery·2017
Same author

Liquid jet delivery method featuring S100A1 gene therapy in the rodent model following acute myocardial infarction.

Gene therapy·2015
Same author

Bochdalek Congenital Diaphragmatic Hernia in an Adult Sheep.

Anatomia, histologia, embryologia·2015
Same author

Expression of vitellogenin receptor gene in the ovary of wild and captive Atlantic bluefin tuna (Thunnus thynnus).

Animal reproduction science·2012
Same journal

A new method of local treatment of rheumatoid and traumatic affections of the joints.

Geriatrics·2010
Same journal

Cardiovascular deterioration.

Geriatrics·2010
Same journal

Some prophylactic suggestions regarding the science of geriatrics.

Geriatrics·2010
Same journal

The senile and prematurely senile skin.

Geriatrics·2010
Same journal

Guillain-Barré's disease in the older age group.

Geriatrics·2010
Same journal

Pancreatitis in geriatric practice.

Geriatrics·2010
See all related articles

Elderly patients face higher risks of side effects from antirheumatic drugs due to altered metabolism and polypharmacy. Central nervous system toxicity is a common, overlooked issue in geriatric patients on these medications.

Area of Science:

  • Geriatric Pharmacology
  • Rheumatology
  • Clinical Toxicology

Background:

  • Elderly individuals often experience altered drug metabolism, polypharmacy, and multiple comorbidities.
  • These factors significantly increase the risk of adverse drug reactions in patients undergoing antirheumatic therapy.

Purpose of the Study:

  • To review the geriatric presentation of central nervous system (CNS) toxicity associated with antirheumatic drugs.
  • To provide practical guidance for avoiding prescribing errors in elderly patients.

Main Methods:

  • Literature review focusing on CNS toxicity in elderly patients treated with antirheumatic medications.
  • Analysis of common risk factors including altered pharmacokinetics and self-medication errors.

Main Results:

Related Experiment Videos

  • Central nervous system (CNS) toxicity is a frequent yet often unrecognized complication in older adults on antirheumatic drugs.
  • Specific drug classes commonly used in rheumatology carry distinct risks for geriatric CNS toxicity.

Conclusions:

  • Antirheumatic drug prescribing in the elderly requires careful consideration of age-related physiological changes and potential drug interactions.
  • Awareness and proactive management of CNS toxicity are crucial for improving patient safety and therapeutic outcomes in geriatric rheumatology.